News

New Search Tool Allows Easy Navigation of Funded Research Projects

This week, we announced the release of a search tool which will enable users on the Meso Foundation’s website to easily search through nearly 100 mesothelioma research projects the organization has funded since its inception.
“As we continue funding important research, it has become very important to create easy ways to sort through that research,” said […]




BREAKING NEWS: Data Released from Anetumab Ravtansine Study

Last week, at the World Conference on Lung Cancer, Dr. Raffit Hassan presented promising data on a novel agent, anetumab ravtansine, also known as BAY 94-9343. Anetumab ravtansine is an antibody-drug conjugate directed against the target molecule mesothelin which is highly expressed on mesotheliomas.
“Anetumab ravtansine shows encouraging efficacy in patients with advanced mesothelioma which warrants […]